Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0EH2
|
||||
| Drug Name |
(S)-1-[(4S,6R)-4-(4,6-Dimethyl-benzo[b]thiophen-2-yl)-2-methyl-piperidin-1-yl]-3-(1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL79543
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H32N2O2S
|
||||
| Canonical SMILES |
C[C@H]1C[C@@H](CCN1C[C@H](O)COc2cccc3[nH]ccc23)c4cc5c(C)cc(C)cc5s4
|
||||
| InChI |
InChI=1S/C27H32N2O2S/c1-17-11-18(2)23-14-26(32-27(23)12-17)20-8-10-29(19(3)13-20)15-21(30)16-31-25-6-4-5-24-22(25)7-9-28-24/h4-7,9,11-12,14,19-21,28,30H,8,10,13,15-16H2,1-3H3/t19-,20+,21-/m0/s1
|
||||
| InChIKey |
SXULKULQYARJNC-HBMCJLEFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.